The company’s research focuses on the Digital Clock and Recall (DCR) assessment, a tool that analyzes not just completion of a task, but the nuances of how a patient performs it. Dr. Ali Jannati, director of cognitive science at Linus Health, will present data showing the DCR outperforms the standard Montreal Cognitive Assessment (MoCA) in real-world clinical settings. By offering higher specificity, the DCR aims to reduce false positives and provide clinicians with greater diagnostic confidence during routine visits.

Beyond basic detection, the firm is addressing the subjective nature of treatment success. Dr. Stina Saunders is presenting findings on the electronic Person-Specific Outcome Measure (ePSOM), a questionnaire that tracks the individual daily priorities of patients—such as managing personal finances or social fluency. By proving that ePSOM functions across different health systems, including in Japan, the company argues that drug efficacy can be measured against what patients actually value. These developments are intended to streamline the path to biomarker testing and ensure that the precision of specialized neurology is accessible in primary care environments.